{"lastModifiedDate":1750087265195,"metaDataObj":{"isNoIndex":false,"isNoFollow":false,"publishedDate":1752248483151,"lastModifiedDate":1750087265195,"keywords":["Press Releases"],"title":"Press Releases","seoSchemas":[{"itemListElement":[{"position":1,"name":"Press Releases","@type":"ListItem"}],"@context":"https://schema.org","@type":"BreadcrumbList"}],"description":"Stay updated with our latest press releases on product launches, strategic partnerships, and charitable initiatives in the life sciences.","pageType":"Press Releases","ogImageMetaInfo":[{"ogTitle":"Press Releases","ogType":"website","ogImage":"https://www.sigmaaldrich.com/deepweb/assets/sigmaaldrich/marketing/global/images/social-media/vibrant-m/vibrant-m.jpg","ogUrl":"/US/en/collections/press","ogDescription":"Stay updated with our latest press releases on product launches, strategic partnerships, and charitable initiatives in the life sciences."}],"translationMethod":null,"canonicalUrl":null},"designPath":"/libs/settings/wcm/designs/default","cssClassNames":"page basicpage","title":"Press Releases","templateName":"service-directional-page-template","language":"en",":items":{"root":{"gridClassNames":"aem-Grid aem-Grid--12 aem-Grid--default--12","columnClassNames":{"bodyresponsivecontainer":"aem-GridColumn aem-GridColumn--default--12 aem-GridColumn--offset--default--0 aem-GridColumn--default--none","topresponsivecontainer":"aem-GridColumn aem-GridColumn--default--12 aem-GridColumn--offset--default--0 aem-GridColumn--default--none"},"columnCount":12,"allowedComponents":{"applicable":false,"components":[{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/aboutus","title":"About Us Text"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/accordion","title":"Accordion"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/audio","title":"Audio"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/author","title":"Author"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/breadcrumb","title":"Breadcrumbs - Page Path"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/button","title":"Button"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/card","title":"Card"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/carousel","title":"Carousel"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/categorysearchresults","title":"Category Search Results"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/cftext","title":"CF Text"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/contact","title":"Contact Component"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/container","title":"Container component"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/dealerlicense","title":"Dealer License"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/dynamicproducttable","title":"Dynamic Product Table"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/event-sidebar","title":"Event Sidebar"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/eventlisting","title":"Event Listing"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/experiencefragment","title":"Experience Fragment"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/featuretiles","title":"Feature Tiles"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/footer","title":"Footer"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/formAssembly","title":"Form Assembly"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/gatedbutton","title":"Gated Button"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/gatedcontent","title":"Gated Content"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/genericPlaceholder","title":"Generic Placeholder"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/globalfooter","title":"Global Footer"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/header","title":"Header"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/herocomponent","title":"Hero Component"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/workflows/horizontal","title":"Workflow Horizontal"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/horizontaltab","title":"Tabbed Horizontal Navigation"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/image","title":"Image"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/leftnavigation","title":"Navigation Model"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/locationmap","title":"Map"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/pressreleasegrid","title":"Related Press releases"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/pressreleaselisting","title":"Press release listing"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/presstext","title":"Region Text"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/primarycontent","title":"Primary Content"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/printsocialsharing","title":"Print Social sharing"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/productRecommendationCarousel","title":"Product Recommendation Carousel"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/productselector","title":"Product Selector Tool"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/promobanner","title":"Promo Banner"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/rawhtml","title":"Raw HTML"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/recommendedSearch","title":"Recommended Search Term"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/reference","title":"Reference"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/relatedContentCarousel","title":"Related Content Carousel"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/relatedcontentgrid","title":"Related Content Grid"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/relatedcontentlinks","title":"Related Content Links"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/relatedproductresources","title":"Related Product Resources"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/relatedproducts","title":"Related Products Carousel"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/relatedproductsrightrail","title":"Related Products Right Rail"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/relatedwebinar","title":"Related Webinar"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/sectiondivider","title":"Section Divider"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/selfServiceReviewForm","title":"Self Service Review Form"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/shopProductRightRail","title":"Shop Product Right Rail"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/sitecontentsearch","title":"Site Content Search"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/sitemap","title":"Site Map"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/speakerpage","title":"Speaker Page"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/speakers-list","title":"Speakers List"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/table","title":"Static Table"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/tagbasedbreadcrumb","title":"Breadcrumbs - Tag Based"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/text","title":"Text"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/textbanner","title":"Text Banner"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/title","title":"Title"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/topPagesCarousel","title":"Top Pages Carousel"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/topnavigation","title":"Top Navigation"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/upcomingeventsgrid","title":"Upcoming Events"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/userEngageCarousel","title":"User Engage Carousel"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/workflows/vertical","title":"Workflow Vertical"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/video","title":"Video"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/webinarlisting","title":"Webinar listing"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/webinarsidebar","title":"Webinar Sidebar"},{"path":"/US/en/collections/press/jcr:content/root/cms-commons/components/content/worldwideofficelisting","title":"Worldwide Office Listing"}]},":items":{"topresponsivecontainer":{"columnClassNames":{"breadcrumb":"aem-GridColumn aem-GridColumn--default--12","text":"aem-GridColumn aem-GridColumn--default--7 aem-GridColumn--offset--default--0 aem-GridColumn--default--none","container_1129208197_43298599":"aem-GridColumn aem-GridColumn--default--4 aem-GridColumn--offset--default--1 aem-GridColumn--default--none","title":"aem-GridColumn aem-GridColumn--default--12"},"cssClassName":"","paddingLeftRight":"0px","gridclassNames":"aem-Grid aem-Grid--default--12","columns":12,"hasFeatureCard":false,"halfGatedContent":false,"id":"container-284d28120e","allowedComponents":{"applicable":false,"components":[]},":items":{"breadcrumb":{"items":[{"url":"/US/en","title":"Home","titleEng":"Home","active":false,"nonClickable":false},{"url":"/US/en/collections/press","title":"Press Releases","titleEng":"Press Releases","active":true,"nonClickable":true}],":type":"cms-commons/components/content/breadcrumb"},"title":{"anchorId":null,"linkURL":null,"text":"Press Releases","openNewTab":false,"type":"h1",":type":"cms-commons/components/content/title"},"text":{"text":"

Whether it’s a new product enabling ground-breaking research, a strategic partnership with a customer, or a charitable partnership that supports our mission, we’ve always got something going on. Below you’ll find our most recent press releases as well as a filter to further streamline your search.

\r\n","richText":true,":type":"cms-commons/components/content/text"},"container_1129208197_43298599":{"columnClassNames":{"button_copy_copy_cop":"aem-GridColumn aem-GridColumn--default--4 aem-GridColumn--offset--default--0 aem-GridColumn--default--none","cq:responsive":"aem-GridColumn aem-GridColumn--default--4","text_1229039497_copy":"aem-GridColumn aem-GridColumn--default--4 aem-GridColumn--offset--default--0 aem-GridColumn--default--none"},"cssClassName":"","paddingLeftRight":"0px","gridclassNames":"aem-Grid aem-Grid--default--4","columns":12,"hasFeatureCard":false,"halfGatedContent":false,"id":"container-548eaeec02","allowedComponents":{"applicable":false,"components":[]},":items":{"text_1229039497_copy":{"text":"

Contact

\r\n

For journalist inquiries only, contact:
\r\nDaniel Sherling
\r\nPhone: +1.314.296.8288

\r\n","richText":true,":type":"cms-commons/components/content/text"},"button_copy_copy_cop":{"theme":"btn-primary","linkType":"_blank","anchorId":null,"isAsset":false,"tagValue":null,"fileName":null,"text":"daniel.sherling@milliporesigma.com","icon":null,"link":"mailto:daniel.sherling@milliporesigma.com","accessibilityLabel":null,"openNewTab":false,":type":"cms-commons/components/content/button"}},":itemsOrder":["text_1229039497_copy","button_copy_copy_cop"],"desktopSpacing":{},"mobileSpacing":{},"authenticatedUserBGColor":"","unauthenticatedUserBGColor":"",":type":"cms-commons/components/content/container"}},":itemsOrder":["breadcrumb","title","text","container_1129208197_43298599"],"desktopSpacing":{},"mobileSpacing":{},"authenticatedUserBGColor":"","unauthenticatedUserBGColor":"",":type":"cms-commons/components/content/container"},"bodyresponsivecontainer":{"columnClassNames":{"bottomcontainer":"aem-GridColumn aem-GridColumn--default--12","cq:responsive":"aem-GridColumn aem-GridColumn--default--12"},"cssClassName":"","paddingLeftRight":"0px","gridclassNames":"aem-Grid aem-Grid--default--12","columns":12,"hasFeatureCard":false,"halfGatedContent":false,"id":"container-d76844f3a1","allowedComponents":{"applicable":false,"components":[]},":items":{"bottomcontainer":{"columnClassNames":{"pressreleaselisting":"aem-GridColumn aem-GridColumn--default--12","sectiondivider":"aem-GridColumn aem-GridColumn--default--12"},"cssClassName":"","paddingLeftRight":"0px","gridclassNames":"aem-Grid aem-Grid--12 aem-Grid--default--12","columns":12,"hasFeatureCard":false,"halfGatedContent":false,"id":"container-3fcba1a64b","allowedComponents":{"applicable":false,"components":[]},":items":{"sectiondivider":{"width":"fullWidth",":type":"cms-commons/components/content/sectiondivider"},"pressreleaselisting":{"anchorId":null,"listItems":[{"date":"2018-12-10","subheadline":null,"url":"/US/en/collections/press/p556613280","categories":["Genomics"],"headline":"MilliporeSigma and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models"},{"date":"2019-08-19T00:00:00.000+02:00","subheadline":"MilliporeSigma today announced that the European, Israeli, South Korean and U.K. intellectual property offices have issued formal notices allowing MilliporeSigma’s patent application claims covering CRISPR gene-editing technology.","url":"/US/en/collections/press/p971670662","categories":["Genomics"],"headline":"MilliporeSigma Granted 20 CRISPR Patents Total Worldwide"},{"date":"2021-04-07","subheadline":null,"url":"/US/en/collections/press/p111685708","categories":["Analytical chemistry"],"headline":"MilliporeSigma press release test 0704 - NA"},{"date":"2021-02-25","subheadline":null,"url":"/US/en/collections/press/p523673038","categories":["Applications"],"headline":"MilliporeSigma-helloworld-NA-25022021-SAM-MilliporeSigma"},{"date":"2021-03-16T00:00:00.000+01:00","subheadline":null,"url":"/US/en/collections/press/p503084158","categories":["Cell culture and cell culture analysis"],"headline":"MilliporeSigma Brings New Renewable Energy to the Grid through Virtual Power Purchase Agreement with Enel Green Power"},{"date":"2018-03-23","subheadline":null,"url":"/US/en/collections/press/p236788551","categories":["Protein biology","Clinical testing and diagnostics manufacturing"],"headline":"SMC"},{"date":"2021-02-04T00:00:00.000-05:00","subheadline":"Test for Teaser PR NA","url":"/US/en/collections/press/p526240868","categories":["Language"],"headline":"Test for Teaser PR"},{"date":"2021-07-16T00:00:00.000+02:00","subheadline":"Press Release 0520 MilliporeSigma NA Teasser","url":"/US/en/collections/press/p356971727","categories":["Page Type"],"headline":"Press Release 0520 MilliporeSigma NA Headline"},{"date":"2021-02-15T00:00:00.000+01:00","subheadline":null,"url":"/US/en/collections/press/p835969568","categories":["Collections"],"headline":"MilliporeSigma Enhances Design for Sustainability Framework, Offers Customers Data-Driven Insights for Greener Solutions - Updated"},{"date":"2021-04-22T00:00:00.000+02:00","subheadline":"MilliporeSigma Press 4/22 Teaser NA","url":"/US/en/collections/press/p673655359","categories":["Analytical chemistry"],"headline":"MilliporeSigma Press 4/22 - NA"},{"date":"2021-05-03T00:00:00.000-04:00","subheadline":"Press Release Jen 552021 NA TEASER","url":"/US/en/collections/press/p459485788","categories":["Analytical chemistry"],"headline":"Press Release Jen 552021 NA"},{"date":"2021-04-15T00:00:00.000-05:00","subheadline":null,"url":"/US/en/collections/press/p477682949","categories":["Genomics","Research and disease areas"],"headline":"press release test collection display issue"},{"date":"2021-01-08","subheadline":"Teaser Headline MilliporeSigma","url":"/US/en/collections/press/p203204908","categories":["Cell culture and analysis"],"headline":"Headline MilliporeSigma"},{"date":"2021-02-12","subheadline":null,"url":"/US/en/collections/press/p465177728","categories":["Technique"],"headline":"Press - NA 12/02"},{"date":"2021-11-03T00:00:00.000-04:00","subheadline":"MilliporeSigma today announced that the Life Science business sector will support SaudiVax Ltd. to design a manufacturing facility to localize manufacturing of biologics and vaccines for the MENA region. ","url":"/US/en/collections/press/p592909577","categories":["Pharmaceutical and biopharmaceutical manufacturing"],"headline":"MilliporeSigma Announces Support of SaudiVax in Becoming First Developer and Manufacturer of Halal Vaccines and Biotherapeutics in Saudi Arabia"},{"date":"2020-11-07T00:00:00.000-05:00","subheadline":"MilliporeSigma and Transcenta, a global biotherapeutics company, have announced a strategic technology collaboration to implement continuous manufacturing for protein therapeutics.","url":"/US/en/collections/press/p595906013","categories":["Pharmaceutical and biopharmaceutical manufacturing"],"headline":"MilliporeSigma and Transcenta Collaborate to Advance Continuous Biomanufacturing, Make the ‘Facility of the Future’ a Reality"},{"date":"2021-10-12T00:00:00.000-04:00","subheadline":"MilliporeSigma today announced the opening of its second Carlsbad, California-based facility, significantly expanding its CDMO footprint. ","url":"/US/en/collections/press/p412283912","categories":["Pharmaceutical and biopharmaceutical manufacturing"],"headline":"MilliporeSigma Announces Completion of New Viral Vector Contract Development Manufacturing Facility for Gene Therapy "},{"date":"2019-07-24T00:00:00.000+02:00","subheadline":"MilliporeSigma today announced the signing of a non-binding Memorandum of Understanding (MoU) with Phanes Therapeutics, Inc. (Phanes) for a collaboration on the development and manufacture of biologics for the treatment of solid tumors.","url":"/US/en/collections/press/p634414679","categories":["Pharmaceutical and biopharmaceutical manufacturing"],"headline":"

MilliporeSigma to Provide BioReliance^® End-to-End Solutions to Phanes Therapeutics

\r\n"},{"date":"2020-02-10T00:00:00.000-05:00","subheadline":"MilliporeSigma today introduced its BrightLab™ cloud-based inventory management and instrument connectivity platform for research scientists.","url":"/US/en/collections/press/p481324393","categories":["Analytical chemistry","Cell culture and cell culture analysis","Chemistry and synthesis","Environmental and cannabis testing","Genomics","Protein biology","Materials science and engineering"],"headline":"MilliporeSigma’s New BrightLab™ Cloud-hosted Software Brings IoT to R&D"},{"date":"2019-05-29T00:00:00.000-04:00","subheadline":"MilliporeSigma today announced the winners of its Advance Biotech Grant program in North America during its Biotech Start-up Summit at the Cambridge Innovation Center. ","url":"/US/en/collections/press/p805267586","categories":["Pharmaceutical and biopharmaceutical manufacturing"],"headline":"MilliporeSigma Awards Grants to Biotechs Focused on Traumatic Brain Injury, Vaccine Development, and Chronic Pain"},{"date":"2019-04-03T00:00:00.000-04:00","subheadline":" MilliporeSigma today announced that it has won an INTERPHEX Exhibitor Award for a new innovation in advancing next- generation bioprocessing.","url":"/US/en/collections/press/p173267088","categories":["Pharmaceutical and biopharmaceutical manufacturing"],"headline":"MilliporeSigma Recognized with INTERPHEX Exhibitor Award for Best New Product"},{"date":"2020-10-06T00:00:00.000+02:00","subheadline":"MilliporeSigma today inaugurated a new $14.4 million industrial water treatment plant at its Jaffrey, New Hampshire, location.","url":"/US/en/collections/press/p734941449","categories":["Environmental and cannabis testing"],"headline":"MilliporeSigma Inaugurates New, Upgraded Onsite Industrial Water Treatment Plant"},{"date":"2020-07-15T00:00:00.000+02:00","subheadline":"MilliporeSigma has announced plans to build a new, $20 million laboratory facility in Buchs, Switzerland to support its rapidly growing reference materials business.","url":"/US/en/collections/press/p283851884","categories":[],"headline":"MilliporeSigma Invests $20 Million in New Switzerland Laboratory"},{"date":"2021-10-05T00:00:00.000-04:00","subheadline":"MilliporeSigma, the U.S. and Canadian Life Science business of Merck KGaA, Darmstadt, Germany, announces that its Life Science business sector has signed an agreement licensing its patented CRISPR-Cas9 technology to California-based Cellecta, Inc. ","url":"/US/en/collections/press/p868297324","categories":["Genomics"],"headline":"MilliporeSigma Announces the Licensing of Foundational CRISPR Technology to Cellecta, Paving Pathway for Development of Next-Generation Treatments "},{"date":"2021-12-13T00:00:00.000-06:00","subheadline":"MoU marks steps towards the first industry-academia collaboration for quantum biophysics medicines in South Korea","url":"/US/en/collections/press/p740186683","categories":[],"headline":"MilliporeSigma Announces MoU with SKKU Institute of Quantum Biophysics for In-depth Scientific Collaboration"},{"date":"2019-03-04T00:00:00.000-05:00","subheadline":"MilliporeSigma today announced that the Canadian Patent Office has allowed MilliporeSigma’s patent application directed to the use of paired CRISPR nickases in eukaryotic cells.","url":"/US/en/collections/press/p198841818","categories":["Genomics"],"headline":"MilliporeSigma Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology"},{"date":"2020-06-30T00:00:00.000-04:00","subheadline":"MilliporeSigma today enhanced its advanced bioprocess portfolio through the acquisition of RESOLUTION Spectra Systems, a Meylan, France-based leader in bioprocess analytical monitoring.","url":"/US/en/collections/press/p232926225","categories":["Pharmaceutical and biopharmaceutical manufacturing"],"headline":"MilliporeSigma Advances Bioprocessing Capabilities with Raman Technology Sensor Acquisition"},{"date":"2020-10-12T00:00:00.000+02:00","subheadline":"MilliporeSigma today announced that it has signed agreements licensing its CRISPR technology to two companies — PanCELLa, a cell therapy firm based in Toronto, Canada, and Takara Bio USA, Inc., a biotechnology company based in Mountain View, California.","url":"/US/en/collections/press/p513695478","categories":["Genomics","Pharmaceutical and biopharmaceutical manufacturing"],"headline":"MilliporeSigma Licenses CRISPR Genome-Editing Technology to PanCELLa and Takara Bio USA"},{"date":"2019-09-19T00:00:00.000+02:00","subheadline":"MilliporeSigma has launched its official flagship store on Alibaba’s 1688.com.","url":"/US/en/collections/press/p482113448","categories":[],"headline":"MilliporeSigma Launches First Flagship Store on Alibaba’s 1688.com to Improve the Customer Experience"},{"date":"2021-08-27T00:00:00.000-04:00","subheadline":"MilliporeSigma today announced a donation of INR 1.7crore (194,000€) over two years to the Indian Institute of Technology (IIT), Bombay to support the development of clinical tests for Covid-19 disease severity assessment.","url":"/US/en/collections/press/p352026778","categories":[],"headline":"MilliporeSigma funds Indian Institute of Technology (IIT) Bombay for Covid-19 research"},{"date":"2019-07-18T00:00:00.000+02:00","subheadline":"MilliporeSigma and the Broad Institute of MIT and Harvard today announced an agreement to offer non-exclusive licenses to CRISPR intellectual property (IP) under their respective control for use in commercial research and product development.","url":"/US/en/collections/press/p780663177","categories":["Genomics"],"headline":"MilliporeSigma and Broad Institute Announce CRISPR License Framework to Encourage Innovation"},{"date":"2021-05-04T00:00:00.000-04:00","subheadline":"MilliporeSigma today announced a partnership with Topco Scientific Co. (TSC), a leading semiconductor supplier in Taiwan, to increase the use of more sustainable materials for the electronics industry.","url":"/US/en/collections/press/p864864756","categories":["sustainability"],"headline":null},{"date":"2019-11-25T00:00:00.000-05:00","subheadline":"MilliporeSigma today announced that the Japan Patent Office and the Intellectual Property Office of Singapore have each allowed its patent application for the use of paired CRISPR nickases, bringing MilliporeSigma’s number of patents to 22 worldwide.","url":"/US/en/collections/press/p835087194","categories":["Genomics"],"headline":"Japan and Singapore Grant CRISPR Patents to MilliporeSigma"},{"date":"2022-01-11T00:00:00.000-06:00","subheadline":"MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt Germany, a leading science and technology company, today announced the expansion of its Stable Isotope Center of Excellence in Miamisburg, Ohio. ","url":"/US/en/collections/press/p694754143","categories":["Pharma and biopharma manufacturing"],"headline":"MilliporeSigma Announces Expansion of Stable Isotope Center of Excellence in Miamisburg, Ohio"},{"date":"2021-07-05T00:00:00.000-04:00","subheadline":"Lab marks five years of continuous operation and 400+ activities, benefitting more than 10,000 customers.","url":"/US/en/collections/press/p602031620","categories":["Pharmaceutical and biopharmaceutical manufacturing"],"headline":"MilliporeSigma’s Tokyo M Lab™ Collaboration Center Commemorates Fifth Anniversary of Supporting Science Community in Japan"},{"date":"2020-07-10T00:00:00.000+02:00","subheadline":"MilliporeSigma today opened its M Lab™ Collaboration Center in Shanghai, the company’s largest of nine centers worldwide. ","url":"/US/en/collections/press/p244108426","categories":["Pharmaceutical and biopharmaceutical manufacturing"],"headline":"MilliporeSigma Opens its Largest M Lab™ Collaboration Center in Shanghai"},{"date":"2021-12-11T00:00:00.000-05:00","subheadline":"Award recognizes early in career scientists for Indonesia-based research ","url":"/US/en/collections/press/p510833476","categories":["Collections"],"headline":"MilliporeSigma Announces Conferring of 2021 Young Scientists Awards"},{"date":"2020-07-29T00:00:00.000-04:00","subheadline":"MilliporeSigma today announced that it won a Top Project of the Year award from Environment + Energy Leader for the company’s DOZN™ system.","url":"/US/en/collections/press/p526425790","categories":["Chemistry and synthesis"],"headline":"

MilliporeSigma’s DOZN™ Green Chemistry Tool Named Top Project of the Year by Environment + Energy Leader

\n"},{"date":"2019-03-19T00:00:00.000+01:00","subheadline":"MilliporeSigma today announced the signing of a non-binding Memorandum of Understanding with Chinese biotech company GenScript for a strategic alliance focusing on plasmid and viral vector manufacturing.","url":"/US/en/collections/press/p889300841","categories":["Genomics","Pharmaceutical and biopharmaceutical manufacturing"],"headline":null},{"date":"2019-03-07T00:00:00.000-05:00","subheadline":"MilliporeSigma is igniting student interest in science with its third annual Curiosity Cube^® mobile science lab tour.","url":"/US/en/collections/press/p130076153","categories":["Collections"],"headline":"

MilliporeSigma Brings Science Education to Students Across North America with Curiosity Cube^® Mobile Science Lab

\r\n"},{"date":"2021-03-15T00:00:00.000-04:00","subheadline":"As part of its ongoing commitment to renewable energy, MilliporeSigma has signed a 12-year, off-site, virtual power purchase agreement with Enel Green Power for the construction of a future wind and storage project in Texas.","url":"/US/en/collections/press/p743679631","categories":["sustainability"],"headline":"MilliporeSigma Brings New Renewable Energy to the Grid through Virtual Power Purchase Agreement with Enel Green Power"},{"date":"2020-09-03T00:00:00.000+02:00","subheadline":"MilliporeSigma today announced the donation of research instruments and materials worth IDR 1.2 billion (€ 74,000) to support the efforts of Eijkman Institute for Molecular Biology, Indonesia","url":"/US/en/collections/press/p278515321","categories":["Pharmaceutical and biopharmaceutical manufacturing","Research and disease areas"],"headline":"MilliporeSigma Supports Eijkman Institute to Expedite Covid-19 Vaccine Development Research"},{"date":"2020-10-07T00:00:00.000-04:00","subheadline":"MilliporeSigma today celebrated the topping-out ceremony for its new membrane production plant in Darmstadt, Germany.","url":"/US/en/collections/press/p383512133","categories":["Clinical testing and diagnostics manufacturing"],"headline":"MilliporeSigma Celebrates Topping-Out Ceremony for New Membrane Production Plant"},{"date":"2019-10-18T00:00:00.000-04:00","subheadline":"MilliporeSigma today announced it has acquired FloDesign Sonics, of Wilbraham, Massachusetts, developer of a unique acoustic cell processing platform for the industrialization of cell and gene therapy manufacturing.","url":"/US/en/collections/press/p289091286","categories":["Pharmaceutical and biopharmaceutical manufacturing"],"headline":null},{"date":"2021-02-04T00:00:00.000-05:00","subheadline":"Building on its commitment to accelerate scientific research and science education, MilliporeSigma has announced seven expanded partnerships with leading nonprofit organizations across the world.","url":"/US/en/collections/press/p791853855","categories":["Collections"],"headline":"MilliporeSigma Continues Commitment to Science Education and Equity with Leading Non-Profits Around the World"},{"date":"2020-10-18T00:00:00.000-04:00","subheadline":"MilliporeSigma today announced that Combined Therapeutics Inc., Cambridge, Massachusetts, has been selected as the North American winner of its 2020 Advance Biotech Grant Program.","url":"/US/en/collections/press/p957312690","categories":["Genomics","Pharmaceutical and biopharmaceutical manufacturing","Research and disease areas"],"headline":"MilliporeSigma Awards Grant to Combined Therapeutics for its Nucleic Acid Platform That, with Virotherapy, Targets Liver Cancer"},{"date":"2019-04-30T00:00:00.000+02:00","subheadline":"MilliporeSigma today announced the handover of a fully equipped microbiological testing laboratory to the Food Safety and Standards Authority of India (FSSAI).","url":"/US/en/collections/press/p646386402","categories":["Food and beverage testing and manufacturing"],"headline":"MilliporeSigma and India’s Food Safety and Standards Authority Partner on Skill Development in Food Safety"},{"date":"2020-04-21T00:00:00.000-04:00","subheadline":"MilliporeSigma today announced a second Carlsbad, California-based facility for its BioReliance® viral and gene therapy service offering.","url":"/US/en/collections/press/p996907918","categories":["Pharmaceutical and biopharmaceutical manufacturing"],"headline":"MilliporeSigma Boosts Commercial Viral Vector and Gene Therapy Manufacturing Capacity"},{"date":"2020-04-07T00:00:00.000+02:00","subheadline":"MilliporeSigma today announced that the United States Patent and Trademark Office has granted the company’s patent for CRISPR-chrom technology.","url":"/US/en/collections/press/p519790754","categories":["Genomics"],"headline":"MilliporeSigma Awarded Second U.S. Patent for CRISPR Gene-Editing Technology"},{"date":"2019-02-04T00:00:00.000+01:00","subheadline":"MilliporeSigma today announced the winners of its Advance Biotech Grant program in Europe. The grant is given to small- and mid-size biotechnology companies that need funding and expertise to get their therapies to market.","url":"/US/en/collections/press/p377045564","categories":["Research and disease areas","Pharmaceutical and biopharmaceutical manufacturing"],"headline":"MilliporeSigma Awards Grants to Biotechs Tackling Cancer and Cardiovascular Disease"},{"date":"2019-05-28T00:00:00.000-04:00","subheadline":"MilliporeSigma today announced that students from St Aloysius’ College in Carrigtwohill have won the company’s 2019 School Science Competition, now in its 15th year.","url":"/US/en/collections/press/p143005399","categories":["Chemistry and synthesis"],"headline":"MilliporeSigma Announces Winners of School Science Competition"},{"date":"2021-06-09T00:00:00.000-04:00","subheadline":"MilliporeSigma will hold a collaborative seminar with the Korea Federation of Women’s Science and Technology Associations (KOFWST) about ways to ensure a safe and healthy laboratory environment for pregnant scientists.","url":"/US/en/collections/press/p536580697","categories":["Research and disease areas"],"headline":"MilliporeSigma Holds Joint Seminar with KOFWST to Address Safe Management of Research Labs"},{"date":"2019-05-20T00:00:00.000+02:00","subheadline":"MilliporeSigma today announced its participation in a collaboration with the Vaccine Formulation Institute and the European Vaccine Initiative.","url":"/US/en/collections/press/p703307506","categories":["Pharmaceutical and biopharmaceutical manufacturing"],"headline":"MilliporeSigma Joins TRANSVAC2 Program to Advance Vaccine Development and Manufacturing"},{"date":"2019-11-11T00:00:00.000-05:00","subheadline":"MilliporeSigma today announced that it has signed a license agreement providing Evotec SE access to MilliporeSigma’s foundational CRISPR intellectual property.","url":"/US/en/collections/press/p421137568","categories":["Genomics"],"headline":"MilliporeSigma Licenses CRISPR Gene-Editing Technology to Evotec"},{"date":"2021-12-29T00:00:00.000-06:00","subheadline":"MilliporeSigma today announced that it has been awarded a $136.7M USD contract award for the construction of a lateral flow membrane production facility over a three-year period at the company’s Sheboygan, Wisconsin site.","url":"/US/en/collections/press/p131921544","categories":["Pharmaceutical and biopharmaceutical manufacturing"],"headline":"MilliporeSigma Announces $136.7 Million U.S. Government Contract Award for New Lateral Flow Membrane Production Facility in Sheboygan, Wisconsin"},{"date":"2021-12-14T00:00:00.000+01:00","subheadline":"MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the Life Science business sector has signed an agreement with biotechnology company Innovative Biotech.","url":"/US/en/collections/press/p408418816","categories":["Pharmaceutical and biopharmaceutical manufacturing"],"headline":"MilliporeSigma Announces Collaboration with Innovative Biotech to Support Establishment of First Vaccine Production Facility in Nigeria"},{"date":"2021-05-20T00:00:00.000-04:00","subheadline":"MilliporeSigma today introduced a new solution improving productivity in the lab through a more flexible and streamlined nucleic acid purification process — GenElute™-E Single Spin purification kits. ","url":"/US/en/collections/press/p819566610","categories":["Protein biology","sustainability"],"headline":"MilliporeSigma Improves Lab Productivity Through Faster and More Sustainable Nucleic Acid Purification"},{"date":"2019-12-18T00:00:00.000-05:00","subheadline":"MilliporeSigma today announced that it has signed a license agreement providing Promega Corp., a global life science manufacturer based in Madison, Wisconsin, access to MilliporeSigma’s foundational CRISPR intellectual property.","url":"/US/en/collections/press/p569232954","categories":["Genomics"],"headline":"MilliporeSigma Licenses Foundational CRISPR Integration Technology to Promega"},{"date":"2019-05-22T00:00:00.000+02:00","subheadline":"Merck KGaA, Darmstadt, Germany, today hosted a panel discussion on the occasion of the 72nd World Health Assembly in Geneva, Switzerland. ","url":"/US/en/collections/press/p461943796","categories":[],"headline":"Experts Discuss Decentralized Manufacturing to Tackle Neglected Tropical Diseases and Promote Universal Health Coverage at World Health Assembly Event"},{"date":"2021-10-06T00:00:00.000-04:00","subheadline":"MilliporeSigma, the U.S. and Canadian life science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, was selected as a Manufacturer of the Year for its Danvers facility at the 6th Annual Manufacturing Awards Ceremony. ","url":"/US/en/collections/press/p403742690","categories":["Collections"],"headline":"MilliporeSigma’s Danvers Facility Honored as a Manufacturer of the Year by Commonwealth’s Legislative Manufacturing Caucus"},{"date":"2020-05-11T00:00:00.000-04:00","subheadline":"MilliporeSigma today announced that two of its CRISPR-Cas9-assisted genome-editing patents have been allowed in the United States.","url":"/US/en/collections/press/p348300932","categories":["Genomics"],"headline":"MilliporeSigma Granted U.S. Patents for Foundational CRISPR-Cas9 Technology"},{"date":"2019-04-02T00:00:00.000+02:00","subheadline":"MilliporeSigma today unveiled its BioContinuum™ Buffer Delivery Platform, a new building block in the BioContinuum™ Platform for next-generation bioprocessing, at INTERPHEX in New York City. ","url":"/US/en/collections/press/p185645431","categories":["Pharmaceutical and biopharmaceutical manufacturing"],"headline":"MilliporeSigma Elevates its BioContinuum™ Platform Strategy to Deliver ‘ContiGuous’ Bioprocessing"},{"date":"2019-01-14T00:00:00.000-05:00","subheadline":"MilliporeSigma today announced that it has been recognized by BioInformatics LLC with a 2018 Life Science Industry Award^® for best use of social media.","url":"/US/en/collections/press/p996301732","categories":["Collections"],"headline":"MilliporeSigma Wins Life Science Industry Award^® for Best Use of Social Media"},{"date":"2021-11-09T00:00:00.000-05:00","subheadline":"MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the retirement of Jean-Phillipe Maurer as Head of Molsheim Operations, effective December 1.","url":"/US/en/collections/press/p924453436","categories":[],"headline":"MilliporeSigma Announces Leadership Changes in France "},{"date":"2020-02-17T00:00:00.000-05:00","subheadline":"MilliporeSigma today announced that it has been selected by Swedish molecular diagnostics firm Elypta as the contract manufacturer for Elypta’s clinical diagnostic liquid biopsy kits.","url":"/US/en/collections/press/p761110524","categories":["Clinical testing and diagnostics manufacturing"],"headline":"MilliporeSigma to Manufacture Elypta’s Liquid Biopsy Kits"},{"date":"2020-01-10T00:00:00.000+01:00","subheadline":"MilliporeSigma today announced the opening of new, non-profit center where Indian students and researchers can learn the latest genome-editing and single-molecule biomolecule biomarker detection technologies from MilliporeSigma experts.","url":"/US/en/collections/press/p311927217","categories":["Genomics"],"headline":"MilliporeSigma and CSIR-IMTECH Open High-tech Skill Development Center"},{"date":"2020-10-13T00:00:00.000+02:00","subheadline":"MilliporeSigma has bolstered its viral vector manufacturing capabilities with the launch of its VirusExpress™ Lentiviral Production Platform.","url":"/US/en/collections/press/p843088580","categories":["Research and disease areas","Pharmaceutical and biopharmaceutical manufacturing","Genomics"],"headline":"MilliporeSigma’s New VirusExpress™ Platform Speeds Development of Cell and Gene Therapies"},{"date":"2019-02-19T00:00:00.000+01:00","subheadline":"MilliporeSigma today announced that the U.S. Patent and Trademark Office has issued a formal notice allowing MilliporeSigma’s patent application directed to its proxy-CRISPR technology.","url":"/US/en/collections/press/p536664867","categories":["Genomics"],"headline":"MilliporeSigma Receives First U.S. Patent for Improved CRISPR Genome-Editing Method"},{"date":"2018-12-18T00:00:00.000-05:00","subheadline":"MilliporeSigma today announced it has extended and expanded its collaboration with Kuraray Europe to exclusively supply pharmaceutical polyvinyl alcohol (PVA) grades and improvements to benefit the pharmaceutical market.","url":"/US/en/collections/press/p185450805","categories":["Pharmaceutical and biopharmaceutical manufacturing"],"headline":"MilliporeSigma Collaborates with Kuraray to Improve Drug Delivery"},{"date":"2021-05-26T00:00:00.000-04:00","subheadline":"To meet the high demand for lipids, a key component of mRNA-based vaccines and therapeutics, MilliporeSigma has launched a new, high-purity synthetic cholesterol product, nine months ahead of schedule.","url":"/US/en/collections/press/p330279199","categories":["Pharmaceutical and biopharmaceutical manufacturing","Pharma and biopharma manufacturing"],"headline":null},{"date":"2020-03-02T00:00:00.000-05:00","subheadline":"MilliporeSigma today launched its LANEXO™ Lab Inventory, Safety and Compliance Management System, a new digital laboratory informatics solution designed to drastically reduce time in labs and improve data quality and traceability.","url":"/US/en/collections/press/p245437355","categories":["Analytical chemistry"],"headline":"MilliporeSigma’s New LANEXO™ System to Improve Scientists’ Productivity in the Lab"},{"date":"2019-05-27T00:00:00.000+02:00","subheadline":"MilliporeSigma today announced the completion of a £2.7 million expansion to its Irvine biopharmaceutical production facility.","url":"/US/en/collections/press/p911758219","categories":[],"headline":"MilliporeSigma Expands Cell Culture Media Production Facility in Irvine"},{"date":"2020-11-20T00:00:00.000-05:00","subheadline":"Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that its Massachusetts-based businesses, MilliporeSigma, EMD Serono, and EMD Performance Materials, have again been named to The Boston Globe’s annual “Top Places to","url":"/US/en/collections/press/p353808037","categories":["Collections"],"headline":"Massachusetts-based Businesses of Merck KGaA, Darmstadt, Germany Named to The Boston Globe’s ‘Top Places to Work’ List"},{"date":"2020-09-09T00:00:00.000+02:00","subheadline":"MilliporeSigma today announced a $65 million expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison, Wisconsin.","url":"/US/en/collections/press/p729860188","categories":["Pharmaceutical and biopharmaceutical manufacturing"],"headline":"MilliporeSigma Announces $65 Million Antibody-Drug Conjugate Manufacturing Expansion"},{"date":"2019-04-23T00:00:00.000-04:00","subheadline":"MilliporeSigma today launched Cyrene™ — a sustainable dipolar aprotic solvent, produced in two steps from a renewable cellulose source.","url":"/US/en/collections/press/p788793405","categories":["Chemistry and synthesis"],"headline":"MilliporeSigma Introduces New Greener Solvent, Cyrene™"},{"date":"2022-01-20T00:00:00.000-06:00","subheadline":"MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that Elevian has been selected as the North American winner of its 2021 Advance Biotech Grant Program","url":"/US/en/collections/press/p799087387","categories":["Page Type"],"headline":"MilliporeSigma Announces Elevian as Winner of its North American Advance Biotech Grant"},{"date":"2019-08-05T00:00:00.000-04:00","subheadline":"MilliporeSigma has acquired BSSN Software, a Darmstadt, Germany-based laboratory informatics company that makes data more readily accessible for ease of integration, collaboration, analysis and lon","url":"/US/en/collections/press/p430664444","categories":["Food and beverage testing and manufacturing","Pharmaceutical and biopharmaceutical manufacturing"],"headline":"MilliporeSigma Acquires BSSN Software to Accelerate Customers’ Digital Transformation in the Lab"},{"date":"2020-11-06T00:00:00.000-05:00","subheadline":" MilliporeSigma today announced the signing of a Letter of Intent with Donghao Lansheng (Group) Co., Ltd.","url":"/US/en/collections/press/p870060755","categories":["Collections"],"headline":"MilliporeSigma to Collaborate with Donghao Lansheng to Pilot New Import Policy in China"},{"date":"2021-10-28T00:00:00.000-04:00","subheadline":"MilliporeSigma today announced that its Life Science business sector has launched new technology and expanded capacity to advance ADC therapies. ","url":"/US/en/collections/press/p179238104","categories":["Chemistry and synthesis"],"headline":"MilliporeSigma Announces New Innovation & Capacity to Advance Next Generation Antibody-drug Conjugate (ADC) Therapies"},{"date":"2020-07-01T00:00:00.000+02:00","subheadline":"A new report details potential paths to solutions to overcoming the global Covid-19 crisis and ways to prepare for or even prevent a future pandemic.","url":"/US/en/collections/press/p560105998","categories":["Pharmaceutical and biopharmaceutical manufacturing"],"headline":"New Report Identifies Paths to Pandemic Resilience"},{"date":"2020-04-30T00:00:00.000-04:00","subheadline":"MilliporeSigma today unveiled the next component of its BioContinuum™ Platform, the Bio4C™ Software Suite, creating a first-of-its-kind ecosystem that combines process control, analytics and plant-level automation.","url":"/US/en/collections/press/p655809204","categories":["Pharmaceutical and biopharmaceutical manufacturing"],"headline":null},{"date":"2019-06-19T00:00:00.000-04:00","subheadline":"Merck KGaA, Darmstadt, Germany, today announced that its Massachusetts-based business sectors, MilliporeSigma, EMD Serono and EMD Performance Materials, have been named to the Boston Business Journal’s annual “Best Places to Work\".","url":"/US/en/collections/press/p906869271","categories":["Collections"],"headline":"Massachusetts-based Business Sectors of Merck KGaA, Darmstadt, Germany Named ‘Best Places to Work’ by Boston Business Journal"},{"date":"2019-09-18T00:00:00.000-04:00","subheadline":"MilliporeSigma today announced an expansion of its Singapore biosafety testing laboratory services.","url":"/US/en/collections/press/p423617667","categories":["Pharmaceutical and biopharmaceutical manufacturing"],"headline":"MilliporeSigma Expands BioReliance^® Viral Clearance Offering in Singapore, Saving Customers Time"},{"date":"2021-05-18T00:00:00.000-04:00","subheadline":"MilliporeSigma today announced that VectorY has been selected as the European winner of its 2021 Advance Biotech Grant Program.","url":"/US/en/collections/press/p466340040","categories":["Pharmaceutical and biopharmaceutical manufacturing","Pharmaceutical and biopharmaceutical manufacturing"],"headline":"MilliporeSigma Announces VectorY as Winner of its Advance Biotech Grant"},{"date":"2019-06-20T00:00:00.000+02:00","subheadline":"MilliporeSigma today announced a national campus tour in China for the company’s first mobile protein research laboratory.","url":"/US/en/collections/press/p631698249","categories":["Protein biology"],"headline":"MilliporeSigma Introduces Mobile Laboratory to Promote Protein Research"},{"date":"2019-03-14T00:00:00.000+01:00","subheadline":"MilliporeSigma today announced a CRISPR core partnership with Zhejiang University in Hangzhou, China.","url":"/US/en/collections/press/p983560379","categories":["Genomics"],"headline":"Zhejiang University Joins MilliporeSigma’s CRISPR Core Partnership Program"},{"date":"2020-04-14T00:00:00.000+02:00","subheadline":"MilliporeSigma and The Jenner Institute today announced that The Jenner Institute has laid the foundation for large-scale production of its Covid-19 vaccine candidate, ChAdOx1 nCoV-19.","url":"/US/en/collections/press/p303481929","categories":["Pharmaceutical and biopharmaceutical manufacturing","Research and disease areas"],"headline":"MilliporeSigma Supports Jenner Institute to Reach First Milestone in Covid-19 Vaccine Manufacturing"},{"date":"2021-11-11T00:00:00.000-05:00","subheadline":"MilliporeSigma announced that the Life Science business sector signed a Memorandum of Understanding with local bio-venture company GI Innovation.","url":"/US/en/collections/press/p546212077","categories":["Cell culture and cell culture analysis"],"headline":"MilliporeSigma Announces Strategic Agreement with GI Innovation to Facilitate Biomedicine Development in Korea"},{"date":"2020-10-08T00:00:00.000+02:00","subheadline":"MilliporeSigma is collaborating with D1Med, a Shanghai-based biopharmaceutical start-up precision-medical company, to accelerate production of D1Med’s 3D cell culture technology applications used in the drug discovery process.","url":"/US/en/collections/press/p148201572","categories":["Cell culture and cell culture analysis"],"headline":"MilliporeSigma Supporting Innovation in China with D1Med Collaboration"},{"date":"2021-01-07","subheadline":"MilliporeSigma today announced the acquisition of AmpTec, a leading Hamburg, Germany-based, mRNA contract development and manufacturing organization (CDMO).","url":"/US/en/collections/press/p206459738","categories":["Genomics"],"headline":"MilliporeSigma Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments, and Diagnostics"},{"date":"2021-10-20T00:00:00.000-04:00","subheadline":"MilliporeSigma today announced that the Life Science business sector entered into a collaboration with Bio-valley (Beijing) Technology Co., LTD (Bio-valley) to establish technical talent training programs for China’s biopharmaceutical industry. ","url":"/US/en/collections/press/p138651616","categories":["Pharmaceutical and biopharmaceutical manufacturing"],"headline":"MilliporeSigma Announces Collaboration with Bio-valley (Beijing) Technology Co., LTD on Biotechnology R&D Platform to Support Talent Development in China"},{"date":"2020-12-07T00:00:00.000-05:00","subheadline":" MilliporeSigma today announced the broadening of its manufacturing footprint with a combined $47 million investment at its production facilities in Danvers, Massachusetts, and Jaffrey, New Hampshire.","url":"/US/en/collections/press/p338658719","categories":["Pharmaceutical and biopharmaceutical manufacturing"],"headline":"MilliporeSigma Expands Production Capacities"},{"date":"2019-11-18T00:00:00.000+01:00","subheadline":"MilliporeSigma today announced the completion of a £9 million expansion to its Gillingham distribution center.","url":"/US/en/collections/press/p641704839","categories":[],"headline":"MilliporeSigma Expands in Gillingham, UK, Boosts Distribution Capabilities"},{"date":"2020-11-10T00:00:00.000-05:00","subheadline":"MilliporeSigma today announced that its first-to-market Blazar™ platform from the BioReliance^® portfolio has won R&D 100 and CPhI Awards for its ability to reduce testing times by up to 80 percent.","url":"/US/en/collections/press/p858474724","categories":["Pharmaceutical and biopharmaceutical manufacturing"],"headline":null},{"date":"2020-05-27T00:00:00.000+02:00","subheadline":"MilliporeSigma and Baylor College of Medicine today announced an extension of their ongoing collaboration to advance a manufacturing platform to fight Covid-19, accelerating the transition to Phase 1 clinical trials.","url":"/US/en/collections/press/p158841807","categories":["Research and disease areas","Pharmaceutical and biopharmaceutical manufacturing"],"headline":null},{"date":"2019-11-17T00:00:00.000-05:00","subheadline":"MilliporeSigma today announced it has received a prestigious R&D 100 Award for its Eshmuno® CP-FT Resin, a first-to-market product used in biopharmaceutical manufacturing.","url":"/US/en/collections/press/p609933032","categories":["Pharmaceutical and biopharmaceutical manufacturing"],"headline":"MilliporeSigma Wins R&D 100 Award for First-to-Market Biopharma Purification Innovation"},{"date":"2020-06-10T00:00:00.000+02:00","subheadline":"MilliporeSigma and 10x Genomics, Inc., a single cell and spatial genomics technologies company, today announced that they have developed a powerful new option for biological experiments.","url":"/US/en/collections/press/p265893918","categories":["Genomics"],"headline":"MilliporeSigma and 10x Genomics Launch Powerful New Option for CRISPR Research"},{"date":"2021-03-31T00:00:00.000+02:00","subheadline":"MilliporeSigma today announced a strategic partnership with the Universitas Indonesia (FMIPA-UI) to establish the first Collaboration Laboratory between the company and the university.","url":"/US/en/collections/press/p979664155","categories":["Pharmaceutical and biopharmaceutical manufacturing","Pharmaceutical and biopharmaceutical manufacturing","Clinical testing and diagnostics manufacturing"],"headline":"MilliporeSigma Establishes Collaboration Laboratory with Universitas Indonesia to Advance Life Science Research"},{"date":"2021-10-21T00:00:00.000-04:00","subheadline":"Korea M Lab™ Collaboration Center marks five years of continuous operation, recording over 540 collaborations and trainings, benefitting over 1,000 biopharmaceutical and biotech customers ","url":"/US/en/collections/press/p360446771","categories":["Pharmaceutical and biopharmaceutical manufacturing"],"headline":"MilliporeSigma Announces the Commemoration of Fifth Anniversary of M Lab™ Collaboration Center in Songdo, South Korea"},{"date":"2022-01-06T00:00:00.000-06:00","subheadline":"MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, announced the signing of a definitive agreement to acquire Exelead.","url":"/US/en/collections/press/p379296495","categories":["Collections"],"headline":"Definitive Agreement to Acquire Exelead will Strengthen MilliporeSigma’s CDMO Offering for mRNA"},{"date":"2021-03-17T00:00:00.000-04:00","subheadline":"MilliporeSigma will add a single-use assembly production unit at its Life Science Center in Molsheim, France. ","url":"/US/en/collections/press/p365840025","categories":["Environmental and cannabis testing","Cell culture and cell culture analysis","Protein biology","Food and beverage testing and manufacturing"],"headline":"MilliporeSigma Accelerates European Expansion Plans for Single-use Products Critical to Manufacturing Vaccines and Lifesaving Therapies"},{"date":"2021-02-15T00:00:00.000-05:00","subheadline":"MilliporeSigma has launched an enhanced Design for Sustainability (DfS) framework, a unique approach to holistically integrate sustainability into products, systems and services.","url":"/US/en/collections/press/p164413512","categories":["sustainability"],"headline":"MilliporeSigma Enhances Design for Sustainability Framework, Offers Customers Data-Driven Insights for Greener Solutions"},{"date":"2019-03-17T00:00:00.000-04:00","subheadline":"MilliporeSigma today announced a new cloud-based, remote lab water service and monitoring capability available on all Milli-Q^® CLX 7000 clinical water purification systems. ","url":"/US/en/collections/press/p795063460","categories":["Analytical chemistry"],"headline":"MilliporeSigma’s Milli-Q^® Connect Combines Deep Water Purification Expertise with Cloud-based Digital Technology"},{"date":"2019-05-07T00:00:00.000+02:00","subheadline":"MilliporeSigma today announced that MDL, a team from Beijing University, has won the company’s first Retrosynthetic Reaction Prediction Contest.","url":"/US/en/collections/press/p367029644","categories":["Chemistry and synthesis"],"headline":"MilliporeSigma Announces Winner of First Retrosynthetic Reaction Prediction Contest"},{"date":"2019-03-20T00:00:00.000+01:00","subheadline":"MilliporeSigma today officially opened its new M Lab™ Collaboration Center in Molsheim, France. ","url":"/US/en/collections/press/p227554253","categories":["Pharmaceutical and biopharmaceutical manufacturing"],"headline":"MilliporeSigma Opens First M Lab™ Collaboration Center in Europe"},{"date":"2020-07-06T00:00:00.000+02:00","subheadline":"MilliporeSigma today announced that VAR2 Pharmaceuticals has been selected as the European winner of its 2020 Advance Biotech Grant Program.","url":"/US/en/collections/press/p804637911","categories":["Pharmaceutical and biopharmaceutical manufacturing"],"headline":"MilliporeSigma Announces VAR2 Pharmaceuticals as Winner of its Advance Biotech Grant"},{"date":"2021-12-16T00:00:00.000+01:00","subheadline":null,"url":"/US/en/collections/press/aem2-236","categories":["Press Releases"],"headline":"AEM2-236"},{"date":null,"subheadline":null,"url":"/US/en/collections/press/aem2-290","categories":[],"headline":"AEM2-290"},{"date":"2022-09-22T00:00:00.000+05:30","subheadline":null,"url":"/US/en/collections/press/aem2-601_qa","categories":["Microbiological analysis"],"headline":"AEM2-601_QA"},{"date":"2022-09-29T00:00:00.000+05:30","subheadline":null,"url":"/US/en/collections/press/press-release-page-0927","categories":[],"headline":"Press Release Page 0927"},{"date":null,"subheadline":null,"url":"/US/en/collections/press/press-release-page-0330","categories":["Press Releases"],"headline":"Press Release Page 0330"},{"date":"2022-11-01T00:00:00.000-05:00","subheadline":"Teaser text.","url":"/US/en/collections/press/uat-press-release-qa-functionality-testing-upgrade-v6-5-14","categories":["Press Releases"],"headline":"UAT | Press Release Template QA Functionality Testing for upgrade v6.5.14"},{"date":"2022-11-25T00:00:00.000-05:00","subheadline":"MilliporeSigma, the U.S. and Canada Life Science business sector of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the closing of the transaction to acquire Exelead, following regulatory clearances and the fulfillment of other customary closing conditions, for approximately USD 780 million in cash. The business combination is expected to enable the Life Science business to provide its customers with comprehensive end-to-end contract development and manufacturing organization (CDMO) services across the mRNA value chain. The Life Science business plans to further invest over € 500 million to scale up Exelead’s technology over the next ten years. ","url":"/US/en/collections/press/AEM2-823-pr","categories":["Press Releases"],"headline":"AEM2-823-PR - - MilliporeSigma Announces Closing of Exelead Acquisition and Plans to Invest More Than € 500 Million in Technology Scale-Up "},{"date":null,"subheadline":null,"url":"/US/en/collections/press/press-release-test-0811","categories":[],"headline":"Press Release Test 0811"},{"date":null,"subheadline":null,"url":"/US/en/collections/press/-hcompany--the-press-release-test-for-aem2-478","categories":[],"headline":"MilliporeSigma The Press Release test for AEM2-478"},{"date":"2023-10-23T00:00:00.000+05:30","subheadline":null,"url":"/US/en/collections/press/press-rel-test-page-1028-rel","categories":["Press Releases"],"headline":"Press Rel Test Page 1028 Rel"},{"date":"2024-04-25T00:00:00.000+05:30","subheadline":null,"url":"/US/en/collections/press/press-release--test-page-0805-release","categories":[],"headline":"Press Release Test Page 0805 Release"},{"date":null,"subheadline":null,"url":"/US/en/collections/press/press-release-test-0819-release","categories":[],"headline":"Press Release Test 0819 Release"},{"date":null,"subheadline":null,"url":"/US/en/collections/press/press-release--test-page-0902-release","categories":[],"headline":"Press Release Test Page 0902 Release"},{"date":"2023-08-30T00:00:00.000+05:30","subheadline":null,"url":"/US/en/collections/press/press-release-test-page-0902-release","categories":["Press Releases"],"headline":"Press Release Test Page 0902 Release"},{"date":"2023-09-08T00:00:00.000-05:00","subheadline":null,"url":"/US/en/collections/press/aem3-305-testing","categories":[],"headline":"aem3-305-testing"},{"date":"2023-09-12T00:00:00.000+05:30","subheadline":null,"url":"/US/en/collections/press/press-release-test-page-for-0916-release","categories":["Press Releases"],"headline":"Press Release Test Page for 0916 Release"},{"date":"2023-10-03T00:00:00.000+05:30","subheadline":null,"url":"/US/en/collections/press/press-release-test-page-0930-release","categories":["Press Releases"],"headline":"Press Release Test Page 0930 Release"},{"date":"2023-10-11T00:00:00.000+05:30","subheadline":null,"url":"/US/en/collections/press/press-rel-test-page-1014-rel","categories":["Press Releases"],"headline":"Press Rel Test Page 1014 Rel"},{"date":"2023-12-28T00:00:00.000+05:30","subheadline":null,"url":"/US/en/collections/press/press-rel-test-page-111-rel","categories":["Press Releases"],"headline":"Press Rel Test Page 111 Rel"},{"date":null,"subheadline":null,"url":"/US/en/collections/press/press-test-page-2911-qa","categories":["Press Releases"],"headline":"Press Test Page 2911 QA"},{"date":"2023-12-21T00:00:00.000+03:00","subheadline":null,"url":"/US/en/collections/press/press-rel-test-page-qa-1216-rel","categories":["Press Releases"],"headline":"Press Rel Test Page QA 1216 Rel"},{"date":"2023-12-28T00:00:00.000+05:30","subheadline":null,"url":"/US/en/collections/press/press-relase-test-page-010624-rel-qa","categories":["Press Releases"],"headline":"Press Relase Test Page 010624 Rel QA"},{"date":"2024-01-25T00:00:00.000+05:30","subheadline":null,"url":"/US/en/collections/press/press-test-page-01202024rel-qa","categories":["Webinar"],"headline":"Press Test Page 01202024rel QA"},{"date":"2024-02-13T00:00:00.000-06:00","subheadline":"Teaser text.","url":"/US/en/collections/press/press-release-test-aem3-605","categories":["Press Releases"],"headline":"Press Release Test AEM3-605"},{"date":"2024-02-29T00:00:00.000+05:30","subheadline":null,"url":"/US/en/collections/press/press-test-page-02032024rel-qa","categories":["Press Releases"],"headline":"Press Test Page 02032024rel QA"},{"date":"2024-02-01T00:00:00.000-05:00","subheadline":null,"url":"/US/en/collections/press/uat-aem3-605-press-listing-displaying-oops-error","categories":["Press Releases"],"headline":"UAT | AEM3-605 | Press Listing displaying OOPS error-SCWR-17301"},{"date":"2024-02-14T00:00:00.000-05:00","subheadline":null,"url":"/US/en/collections/press/aem3-605-press-release-test","categories":["Press Releases"],"headline":"AEM3-605 - Press Release Listing"},{"date":"2024-08-01T00:00:00.000-04:00","subheadline":"MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, today announced that the company’s Life Science business has closed the transaction to acquire Mirus Bio.","url":"/US/en/collections/press/closing-of-mirus-bio-acquisition","categories":["Press Releases"],"headline":"MilliporeSigma Announces Closing of Mirus Bio Acquisition, Bolstering Viral Vector Bioprocessing Offering"},{"date":"2024-09-09T00:00:00.000-05:00","subheadline":"MilliporeSigma has partnered with the Emmy^® and Golden Globe^® Award-winning ABC series \"Abbott Elementary\" to raise awareness around STEM education.","url":"/US/en/collections/press/milliporesigma-abbott-elementary","categories":["Press Releases"],"headline":"MilliporeSigma and ABC’s Hit Comedy Series 'Abbott Elementary' Bring Hands-On STEM to Schools Nationwide"},{"date":"2024-09-03T00:00:00.000-04:00","subheadline":"MilliporeSigma today announced that the company’s Life Science business achieved EXCiPACT cGMP certification for PAMs at its major global CCM production sites.","url":"/US/en/collections/press/industry-first-excipact-certification-for-cell-culture-media-manufacturing","categories":["Press Releases"],"headline":"MilliporeSigma Receives Industry First EXCiPACT Certification for Cell Culture Media Manufacturing"},{"date":"2024-09-10T00:00:00.000-05:00","subheadline":"MilliporeSigma launched the first single-use reactor specifically designed to manufacture antibody drug conjugates (ADCs).","url":"/US/en/collections/press/mobius-adc","categories":["Press Releases"],"headline":"MilliporeSigma Launches Single-Use Reactor Designed to Accelerate Antibody Drug Conjugate Manufacturing"},{"date":"2024-10-09T00:00:00.000-04:00","subheadline":"MilliporeSigma has opened its new €290 million biosafety testing facility in Rockville, Maryland, USA.","url":"/US/en/collections/press/new-biosafety-facility-rockville-md","categories":["Press Releases"],"headline":"MilliporeSigma Opens New €290 Million Biosafety Testing Facility in Rockville, Maryland, USA"},{"date":"2024-10-29T00:00:00.000-04:00","subheadline":"MilliporeSigma today announced a $76 million expansion of its ADC manufacturing capabilities and capacity at its Bioconjugation Center of Excellence facility in St. Louis, Missouri.","url":"/US/en/collections/press/adc-manufacturing-for-novel-cancer-therapies","categories":["Press Releases"],"headline":"MilliporeSigma Invests $76 Million to Expand ADC Manufacturing for Novel Cancer Therapies"},{"date":"2024-12-17T00:00:00.000-06:00","subheadline":"HUB internationally recognized pioneer in organoid development","url":"/US/en/collections/press/advancing-next-generation-biology-portfolio","categories":["Press Releases"],"headline":"MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio"},{"date":"2025-01-06T00:00:00.000-06:00","subheadline":"HUB internationally recognized pioneer in organoid development","url":"/US/en/collections/press/hub-organoids-acquisition","categories":["Press Releases"],"headline":"MilliporeSigma Acquires HUB Organoids Holding B.V., Expands Next-Gen Biology Portfolio"},{"date":"2025-01-23T00:00:00.000-05:00","subheadline":"Custom robotic workstation automates company’s broad portfolio of biology assays for academia, biotech, and pharma","url":"/US/en/collections/press/opentrons-partnership","categories":["Press Releases"],"headline":"MilliporeSigma Partners with Opentrons Labworks, Inc., supporting Lab of the Future"},{"date":"2024-07-24T00:00:00.000-04:00","subheadline":"MilliporeSigma has signed a non-binding MoU with Gene Therapy Research Institution Co., Ltd. (GTRI), a Japanese clinical-stage biotech start-up specializing in gene therapy using adeno-associated virus (AAV) vectors.","url":"/US/en/collections/press/mou-with-gene-therapy-research-institution","categories":["Press Releases"],"headline":"MilliporeSigma Signs MoU with Gene Therapy Research Institution to Accelerate Viral Vector-based Gene Therapy for Parkinson’s Disease"},{"date":"2024-04-17T00:00:00.000-05:00","subheadline":"MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, officially kicked off its global 2024 Curiosity Cube tour today in Darmstadt, Germany.","url":"/US/en/collections/press/curiosity-cube-tour-2024","categories":["Press Releases"],"headline":"MilliporeSigma Inspires Students to Explore STEM Careers with 2024 Curiosity Cube Tour"},{"date":"2024-01-24T00:00:00.000-05:00","subheadline":"MilliporeSigma announced that the Life Science business sector entered into a non-binding MoU with Mycenax Biotech to explore cooperation to bring innovative and high-capacity bioprocessing solutions to Taiwan and other international markets.","url":"/US/en/collections/press/mou-mycenax-biotech","categories":["Press Releases"],"headline":"MilliporeSigma Announces a Non-Binding MoU with Mycenax Biotech to Drive Innovation in Bioprocessing Technology"},{"date":"2023-06-06T00:00:00.000-05:00","subheadline":"MilliporeSigma announced that Proteologix US Inc. (“Proteologix”) has been selected as the North American winner of its 12th Advance Biotech Grant program.","url":"/US/en/collections/press/proteologix-winner-north-american-advance-biotech-grant","categories":["Press Releases"],"headline":"MilliporeSigma Announces Proteologix as Winner of its North American Advance Biotech Grant"},{"date":"2023-05-31T00:00:00.000-04:00","subheadline":"According to a recent study sponsored by the Life Science business of Merck KGaA, Darmstadt, Germany, mRNA technology is a “game-changer” for Asia-Pacific (APAC) vaccine manufacturers. Nearly 40 manufacturers participated in the survey.","url":"/US/en/collections/press/game-changer-for-asia-pacific-vaccine-manufacturers","categories":["Press Releases"],"headline":"Life Science Business of Merck KGaA, Darmstadt, Germany Study: mRNA Technology a ‘Game Changer’ for Asia-Pacific Vaccine Manufacturers"},{"date":"2023-03-27T00:00:00.000-04:00","subheadline":"Partnership to support Beyond Benign’s online learning platform and higher education program","url":"/US/en/collections/press/expanded-partnership-with-beyond-benign","categories":["Press Releases"],"headline":"MilliporeSigma Announces Expanded Partnership with Beyond Benign to Increase Global Access to Green Chemistry Education"},{"date":"2022-10-04T00:00:00.000-05:00","subheadline":"The Life Science business of Merck KGaA, Darmstadt, Germany, has opened a commercial facility for its new Millipore^® CTDMO Services offering at the company’s site in Martillac, France.","url":"/US/en/collections/press/boost-commercial-capacity-ctdmo-services","categories":["Press Releases"],"headline":"MilliporeSigma Announces a Boost in Commercial Capacity in France as Part of New Millipore^® CTDMO Services"},{"date":"2022-09-08T00:00:00.000-04:00","subheadline":"Merck, a leading science and technology company, strengthens its manufacturing capabilities for single-use assemblies","url":"/US/en/collections/press/investment-to-strengthen-manufacturing-capabilities-in-molsheim-france","categories":["Press Releases"],"headline":"MilliporeSigma Invests More Than € 130 Million to Strengthen Manufacturing Capabilities in Molsheim, France"},{"date":"2018-12-10T00:00:00.000-06:00","subheadline":"MilliporeSigma, a leader in genome editing, today announced a strategic alliance in the CRISPR/Cas9 rodent model market with France-based biotechnology company genOway.","url":"/US/en/collections/press/genoway-crispr-cas9-strategic-alliance-to-develop-rodent-models","categories":["Press Releases"],"headline":"MilliporeSigma and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models"},{"date":"2020-03-03T00:00:00.000-05:00","subheadline":"MilliporeSigma today launched its LANEXO^® Lab Inventory, Safety and Compliance Management System, a new digital laboratory informatics solution designed to drastically reduce time in labs and improve data quality and traceability.","url":"/US/en/collections/press/new-lanexo-system-to-improve-scientists-productivity","categories":[],"headline":"MilliporeSigma’s New LANEXO^® System to Improve Scientists’ Productivity in the Lab"},{"date":"2022-09-21T00:00:00.000-05:00","subheadline":"MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, today announced the opening of a viral clearance (VC) laboratory as part of the first building phase of its new € 29 million China Biologics Testing Center.","url":"/US/en/collections/press/new-29-million-euro-biologics-testing-center","categories":["Press Releases"],"headline":"MilliporeSigma Announces Opening of New € 29 Million Biologics Testing Center in Shanghai"},{"date":"2022-05-23T00:00:00.000-05:00","subheadline":"The investment, which is the largest in a single site ever for the Life Science business sector, significantly increases membrane manufacturing capacities and enables the construction of a new filtration manufacturing facility.","url":"/US/en/collections/press/expansion-membrane-filtration-manufacturing-ireland","categories":["Press Releases"],"headline":"MilliporeSigma Invests More Than €440 Million and Expands its Membrane and Filtration Manufacturing in Ireland"},{"date":"2022-04-28T00:00:00.000-05:00","subheadline":"MilliporeSigma’s First Asia Pacific Mobius^® Single-Use Manufacturing Center in Wuxi, China","url":"/US/en/collections/press/investment-to-accelerate-single-use-manufacturing-in-china","categories":["Press Releases"],"headline":"MilliporeSigma Announces Investment of Approximately € 100 Million to Accelerate Single-Use Manufacturing in China"},{"date":"2022-05-18T00:00:00.000-05:00","subheadline":"MilliporeSigma today announced that the Life Science business further enhanced its commitment to Science, Technology, Engineering and Math (STEM) education, with the launch of its 2022 Curiosity Cube^® mobile science lab in Europe and North America.","url":"/US/en/collections/press/kick-off-global-curiosity-cube-mobile-lab","categories":["Press Releases"],"headline":"MilliporeSigma Announces the Expansion of Hands-On Science Education Program with Kick-off of Global Curiosity Cube^® Mobile Lab"},{"date":"2022-06-14T00:00:00.000-05:00","subheadline":"MilliporeSigma collaborates with Agilent Technologies to advance Process Analytical Technologies (PAT).","url":"/US/en/collections/press/collaboration-agilent-technologies","categories":["Press Releases"],"headline":"MilliporeSigma Announces Collaboration with Agilent Technologies to Fill Industry Gap in Process Analytical Technologies for Downstream Processing"},{"date":"2022-06-21T00:00:00.000-07:00","subheadline":"MilliporeSigma doubles high-potent active pharmaceutical ingredients (HPAPI) production capacity at Verona, Wisconsin facility.","url":"/US/en/collections/press/cdmo-facility-to-address-demand-for-critical-cancer-therapies","categories":["Press Releases"],"headline":"MilliporeSigma Opens €59M CDMO Facility for Cancer Therapies"},{"date":"2022-06-29T00:00:00.000-05:00","subheadline":"MilliporeSigma signed a non-binding Memorandum of Understanding (MoU) with the new biologics business of Lotte Group, outlining a planned collaboration to establish Lotte’s biologics manufacturing capabilities in the USA.","url":"/US/en/collections/press/mou-lotte-biologics-for-biologics-manufacturing","categories":["Press Releases"],"headline":"MilliporeSigma Signs MoU with Lotte Biologics for Biologics Manufacturing"},{"date":"2022-07-19T00:00:00.000-05:00","subheadline":"7,000 solar panels produce energy to power 700 homes, Part of We Energies’ “Solar Now” program, bringing more renewable energy to Wisconsin, Reinforces the company’s long-term commitment to renewable energy.","url":"/US/en/collections/press/new-solar-panels-wisconsin-site","categories":["Press Releases"],"headline":"New Solar Panels at MilliporeSigma’s Wisconsin, USA Site Add Renewable Energy to Power Grid"},{"date":"2022-07-18T00:00:00.000-04:00","subheadline":"New facility to manufacture the company’s Hi-Flow™ Plus lateral flow membrane used in rapid diagnostic test kit manufacturing, including Covid-19.","url":"/US/en/collections/press/company-first-lateral-flow-membrane-production-facility-in-the-united-states","categories":["Press Releases"],"headline":"Life Science Business of MilliporeSigma Breaks Ground on Company’s First Lateral Flow Membrane Production Facility in the United States"},{"date":"2022-08-08T00:00:00.000-04:00","subheadline":"MilliporeSigma, a leading science and technology company, has launched the VirusExpress^® 293 Adeno-Associated Virus (AAV) Production Platform, making it one of the first CDMOs and technology-developers to provide a full viral vector manufacturing offering.","url":"/US/en/collections/press/virusexpress-aav","categories":["Press Releases"],"headline":"MilliporeSigma Becomes One of the First CDMOs to Provide Full Viral Vector Offering with Launch of VirusExpress^® 293 Adeno-Associated Virus Production Platform"},{"date":null,"subheadline":null,"url":"/US/en/collections/press/602-pr","categories":["Press Releases"],"headline":"602"},{"date":null,"subheadline":null,"url":"/US/en/collections/press/test-pr","categories":["Press Releases"],"headline":"Test PR"},{"date":"2022-01-26T00:00:00.000-06:00","subheadline":"MilliporeSigma, a leading science and technology company, today announced that the Life Science business sector signed a non-binding Memorandum of Understanding (MoU) with ID Pharma, the advanced medical business within I’rom Group, outlining its planned support of the development and manufacturing of leading-edge gene therapy.","url":"/US/en/collections/press/mou-with-id-pharma-to-accelerate-development-and-manufacturing-of-gene-therapy","categories":["Press Releases"],"headline":"MilliporeSigma Announces MoU with ID Pharma to Accelerate Development and Manufacturing of Gene Therapy"},{"date":"2022-02-07T00:00:00.000-05:00","subheadline":"MilliporeSigma today announced several organizational changes and a new operating model to support the long-term growth strategy of the Life Science business sector and to better serve the evolving needs of its global customers.","url":"/US/en/collections/press/organizational-transformation-strengthen-cdmo-offering-accelerate-future-growth","categories":["Press Releases"],"headline":"MilliporeSigma Announces Organizational Transformation to Strengthen CDMO Offering and Accelerate Future Growth"},{"date":"2022-02-15T00:00:00.000-06:00","subheadline":"MilliporeSigma's Life Science business sector has entered into a collaboration with Waters Corporation to build and expand an Extractables and Leachables (E&L) Reference Library to include ion mobility measurements","url":"/US/en/collections/press/collaborate-extractables-leachables-reference-library","categories":["Press Releases"],"headline":"MilliporeSigma and Waters to Collaborate on Extractables and Leachables Reference Library"},{"date":"2022-02-22T00:00:00.000-08:00","subheadline":"MilliporeSigma, the U.S. and Canada Life Science business sector of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the closing of the transaction to acquire Exelead, following regulatory clearances and the fulfillment of other customary closing conditions, for approximately USD 780 million in cash. The business combination is expected to enable the Life Science business to provide its customers with comprehensive end-to-end contract development and manufacturing organization (CDMO) services across the mRNA value chain. The Life Science business plans to further invest over € 500 million to scale up Exelead’s technology over the next ten years.","url":"/US/en/collections/press/closing-of-exelead-acquisition","categories":["Press Releases"],"headline":"MilliporeSigma Renewable Energy Initiative"},{"date":"2022-04-05T00:00:00.000-05:00","subheadline":"MilliporeSigma to become the first company to offer a fully integrated ecosystem for advanced process technologies.","url":"/US/en/collections/press/mast-acquisition-announced","categories":["Press Releases"],"headline":"MilliporeSigma Announces Acquisition of MAST^® Platform from Lonza, a Leading Automated Bioreactor Sampling System to Advance BioProcessing Capabilities"},{"date":"2022-04-21T00:00:00.000-05:00","subheadline":"ReadyStream^® system offers automated media preparation to conveniently provide a large volume of preheated media, eliminates five time-consuming steps.","url":"/US/en/collections/press/readystream-system","categories":["Press Releases"],"headline":"MilliporeSigma Transforms Media Preparation and Dispensing with New ReadyStream^® System"},{"date":"2022-04-14T00:00:00.000-05:00","subheadline":"ZooMAb^® antibodies first-ever antibody to be recognized for low-environmental impact by My Green Lab","url":"/US/en/collections/press/zoomab-antibodies-earns-act-label-my-green-lab","categories":["Press Releases"],"headline":"MilliporeSigma’s ZooMAb^® Antibodies Earns First-Ever ACT Label from My Green Lab"},{"date":"2022-11-07T00:00:00.000-06:00","subheadline":"MilliporeSigma, a leading science and technology company, today announced a collaboration with Biotheus.","url":"/US/en/collections/press/biotheus-collaboration","categories":["Press Releases"],"headline":"MilliporeSigma Announces Collaboration with Biotheus to Accelerate Drug Submission and Approval Process for Biopharmaceutical Industry in China"},{"date":"2022-11-16T00:00:00.000-06:00","subheadline":"Merck invests more than € 290 million in its biosafety testing capacity at Rockville, Maryland, USA.","url":"/US/en/collections/press/investment-in-drug-safety-testing-capacity","categories":["Press Releases"],"headline":"MilliporeSigma Invests € 290 Million in U.S. Drug Safety Testing Capacity"},{"date":"2022-12-06T00:00:00.000-06:00","subheadline":"MilliporeSigma a leading science and technology company, has acquired Massachusetts-based Erbi Biosystems.","url":"/US/en/collections/press/micro-bioreactor-with-erbi-biosystems-acquisition","categories":["Press Releases"],"headline":"MilliporeSigma Gains Leading Perfusion Micro-Bioreactor with Erbi Biosystems Acquisition"},{"date":"2022-12-07T00:00:00.000-08:00","subheadline":"Non-binding MoU signed between MilliporeSigma and Synplogen for collaborative initiatives.","url":"/US/en/collections/press/mou-with-synplogen","categories":["Press Releases"],"headline":"MoU: MilliporeSigma & Synplogen for Gene Therapy"},{"date":"2023-04-26T00:00:00.000-05:00","subheadline":"Over 250 events expected to reach more than 45,000 future scientists on two continents. Hands-on experiments to focus on the impact of contamination on the planet and everyday life.","url":"/US/en/collections/press/2023-curiosity-cube-mobile-lab-tour","categories":["Press Releases"],"headline":"MilliporeSigma Kicks Off 2023 Curiosity Cube Mobile Lab Tour"},{"date":"2023-04-24T00:00:00.000-05:00","subheadline":"MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, today announced the launch of its Ultimus® Single-Use Process Container Film.","url":"/US/en/collections/press/ultimus-film-to-offer-superior-strength-and-leak-resistance-in-single-use-assemblies","categories":["Press Releases"],"headline":"MilliporeSigma Launches Ultimus^® Film to Offer Superior Strength and Leak Resistance in Single-use Assemblies"},{"date":"2023-05-02T00:00:00.000-07:00","subheadline":"MilliporeSigma partners with MOTIE and Daejeon City for a new Asia-Pacific BioProcessing Center to advance life science.","url":"/US/en/collections/press/new-asia-pacific-bioprocessing-production-center-in-south-korea","categories":["Press Releases"],"headline":"MilliporeSigma Signs MoU for New BioProcessing Center"},{"date":"2023-05-31T00:00:00.000-04:00","subheadline":"Responds to global demand for biosafety testing for drug development and commercialization. Expansion creates nearly 500 new jobs in Glasgow and Stirling.\r\nCompany’s investment to boost global testing capacity now tops € 350 million since mid-2022.","url":"/US/en/collections/press/global-commitment-to-biosafety-testing-with-35-million-investment-in-scotland","categories":["Press Releases"],"headline":"Merck Increases Global Commitment to Biosafety Testing With € 35 Million Investment in Scotland"},{"date":"2023-06-29T00:00:00.000-05:00","subheadline":"MilliporeSigma is expanding production capacity for highly purified reagents with a € 70 million investment at Nantong, China manufacturing site.","url":"/US/en/collections/press/expand-reagent-manufacturing-china","categories":["Press Releases"],"headline":"MilliporeSigma Invests Approximately € 70 Million to Expand Reagent Manufacturing in China"},{"date":"2023-07-12T00:00:00.000-04:00","subheadline":"Lenexa, Kansas, USA facility becomes company’s largest dry powder cell culture media facility and Center of Excellence","url":"/US/en/collections/press/cell-culture-media-production-expansion-kansas","categories":["Press Releases"],"headline":"Merck Invests € 23 Million to Expand Cell Culture Media Production in Kansas, USA"},{"date":"2023-09-26T00:00:00.000-05:00","subheadline":"MilliporeSigma is the first CTDMO to offer integrated services for all critical stages of mRNA development, manufacturing, and commercialization, including products and testing.","url":"/US/en/collections/press/first-provider-fully-integrated-mrna-services","categories":["Press Releases"],"headline":"MilliporeSigma to Become First Provider to Offer Fully Integrated mRNA Services"},{"date":"2023-11-14T00:00:00.000-06:00","subheadline":"Accelerates digitalization in labs and manufacturing by offering traceable digital records of physical reference materials.","url":"/US/en/collections/press/chemistwin-launched-digital-reference-material-platform-analytical-testing","categories":["Press Releases"],"headline":"MilliporeSigma Launches ChemisTwin™, First Ever Digital Reference Materials Platform for Analytical Testing"},{"date":"2023-12-05T00:00:00.000-05:00","subheadline":"Combines generative AI, machine learning and computer-aided drug-design to increase the success rate of new drugs and therapies","url":"/US/en/collections/press/first-ever-ai-solution-to-integrate-drug-discovery-and-synthesis","categories":["Press Releases"],"headline":"MilliporeSigma Launches First Ever AI Solution to Integrate Drug Discovery and Synthesis"},{"date":"2024-03-20T00:00:00.000-04:00","subheadline":"MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, invests more than €300 million into a new Bioprocessing Production Center in Daejeon, South Korea.","url":"/US/en/collections/press/bioprocessing-production-center-in-daejeon-south-korea","categories":["Press Releases"],"headline":"MilliporeSigma Invests More than € 300 Million in New Life Science Production Site in Korea"},{"date":"2024-04-16T00:00:00.000-04:00","subheadline":"MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, launched the first all-in-one, validated genetic stability assay of its kind.","url":"/US/en/collections/press/first-all-in-one-genetic-stability-assay-to-accelerate-biosafety-testing","categories":["Press Releases"],"headline":"MilliporeSigma Launches First All-in-One Genetic Stability Assay to Accelerate Biosafety Testing"},{"date":"2024-05-22T00:00:00.000-05:00","subheadline":"MilliporeSigma today announced the signing of a definitive agreement to acquire Mirus Bio for US$ 600 million.","url":"/US/en/collections/press/agreement-to-acquire-mirus-bio","categories":["Press Releases"],"headline":"MilliporeSigma Signs Definitive Agreement to Acquire Mirus Bio, Furthering Ambition to Be a Leading Supplier for Viral Vector Manufacturing"},{"date":"2024-05-28T00:00:00.000-05:00","subheadline":"MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, has launched its M-Trace^® Software & Mobile App, a comprehensive data tracking solution to digitize sterility testing.","url":"/US/en/collections/press/software-complete-data-traceability-microbial-quality-control","categories":["Press Releases"],"headline":"MilliporeSigma Launches First Software for Complete Data Traceability in Microbial Quality Control"},{"date":"2024-05-29T00:00:00.000-04:00","subheadline":"MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt Germany, a leading science and technology company, has signed a non-binding Memorandum of Understanding (MoU) with KAIST.","url":"/US/en/collections/press/mou-with-kaist-to-advance-scientific-collaboration","categories":["Press Releases"],"headline":"MilliporeSigma Signs MoU with KAIST to Advance Scientific Collaboration"},{"date":"2024-06-04T00:00:00.000-04:00","subheadline":"MilliporeSigma announced today that Siren Biotechnology has been selected as the North American winner of its 13th Advance Biotech Grant Program.","url":"/US/en/collections/press/siren-biotechnology-winner-advance-biotech-grant-program","categories":["Press Releases"],"headline":"MilliporeSigma Announces Siren Biotechnology as Winner of its North American Advance Biotech Grant"},{"date":"2024-06-06T00:00:00.000-04:00","subheadline":"Expands facility by 25,000 square meters, nearly doubling size, adds new down filling capabilities and distribution space for Life Science customers, employs more than 470 people, including engineers, manufacturing, and distribution experts","url":"/US/en/collections/press/investment-to-expand-schnelldorf-distribution-center","categories":["Press Releases"],"headline":"MilliporeSigma Announces Completion of € 180 Million Schnelldorf Distribution Center Expansion"},{"date":"2024-06-11T00:00:00.000-04:00","subheadline":"Facility to provide production-related quality control services for Life Science business and brings together 135 employees and various functions into one ~10,000 m2 building.","url":"/US/en/collections/press/new-quality-control-facility-darmstadt","categories":["Press Releases"],"headline":"MilliporeSigma Announces € 62 Million Investment in New Quality Control Facility in Darmstadt, Germany"},{"date":"2024-06-18T00:00:00.000-04:00","subheadline":"SMC^® immunoassay technology from MilliporeSigma provides new understanding of cell dysfunction to slow disease progression","url":"/US/en/collections/press/mjf-offer-service-to-advance-parkinsons-research","categories":["Press Releases"],"headline":"MilliporeSigma and The Michael J. Fox Foundation Offer Service to Advance Parkinson’s research"},{"date":"2024-07-03T00:00:00.000-04:00","subheadline":"MilliporeSigma announced that the Life Science business sector entered into a non-binding Memorandum of Understanding (MoU) with Afrigen Biologics to support the development of an mRNA vaccine technology platform.","url":"/US/en/collections/press/mou-with-afrigen-biologics","categories":["Press Releases"],"headline":"MilliporeSigma Announces Non-Binding MoU with Afrigen Biologics for Development of mRNA Vaccine Technology Platform"},{"date":"2025-04-24T00:00:00.000-04:00","subheadline":"MilliporeSigma today launched its global 2025 Curiosity Cube tour.","url":"/US/en/collections/press/curiosity-cube-2025","categories":["Press Releases"],"headline":"Curiosity Cube 2025: MilliporeSigma’s Mobile Science Labs Tour Globally to Bring STEM Education to Students"},{"date":"2025-06-18T00:00:00.000-05:00","subheadline":"MilliporeSigma today announced Neoclease as the winner of the 2025 North American Advance Biotech Grant.","url":"/US/en/collections/press/neoclease-winner-2025-north-american-advanced-biotech-grant","categories":["Press Releases"],"headline":"MilliporeSigma Announces Neoclease as Winner of 2025 North American Advance Biotech Grant"}],":type":"cms-commons/components/content/pressreleaselisting"}},":itemsOrder":["sectiondivider","pressreleaselisting"],"desktopSpacing":{},"mobileSpacing":{},"authenticatedUserBGColor":"","unauthenticatedUserBGColor":"",":type":"cms-commons/components/content/container"}},":itemsOrder":["bottomcontainer"],"desktopSpacing":{},"mobileSpacing":{},"authenticatedUserBGColor":"","unauthenticatedUserBGColor":"",":type":"cms-commons/components/content/container"}},":itemsOrder":["topresponsivecontainer","bodyresponsivecontainer"],":type":"wcm/foundation/components/responsivegrid"}},":itemsOrder":["root"],":type":"cms-commons/components/structure/page",":hierarchyType":"page",":path":"/US/en/collections/press"}